Live Price
Live Volume
Summit Therapeutics Market Segments
Overnight
*No Trades in Segment
After Hours
| Open | $14.63 |
|---|---|
| Close | $14.55 |
| Low | $14.50 |
| Low Change | -0.13 (-0.89%) |
| High | $14.69 |
| High Change | +0.06 (+0.41%) |
| Range | $0.19 |
| Volume | 541.367K |
| Dollar Volume | $7.88M |
Regular Trading Hours
| Open | $15.39 |
|---|---|
| Close | $14.65 |
| Low | $14.56 |
| Low Change | -0.83 (-5.39%) |
| High | $15.41 |
| High Change | +0.02 (+0.13%) |
| Range | $0.85 |
| Volume | 3.772M |
| Dollar Volume | $55.25M |
Premarket
| Open | $15.49 |
|---|---|
| Close | $15.36 |
| Low | $15.35 |
| Low Change | -0.14 (-0.90%) |
| High | $15.50 |
| High Change | +0.01 (+0.06%) |
| Range | $0.15 |
| Volume | 16.11K |
| Dollar Volume | $247.40K |
After Hours Yesterday
| Open | $15.37 |
|---|---|
| Close | $15.45 |
| Low | $15.28 |
| Low Change | -0.09 (-0.56%) |
| High | $15.54 |
| High Change | +0.17 (+1.10%) |
| Range | $0.25 |
| Volume | 452.256K |
| Dollar Volume | $6.99M |
Regular Trading Hours Yesterday
| Open | $15.09 |
|---|---|
| Close | $15.37 |
| Low | $15.08 |
| Low Change | -0.01 (-0.07%) |
| High | $15.55 |
| High Change | +0.46 (+3.05%) |
| Range | $0.47 |
| Volume | 3.775M |
| Dollar Volume | $58.02M |
Premarket Yesterday
| Open | $15.06 |
|---|---|
| Close | $15.06 |
| Low | $14.88 |
| Low Change | -0.18 (-1.18%) |
| High | $15.18 |
| High Change | +0.12 (+0.80%) |
| Range | $0.30 |
| Volume | 41.657K |
| Dollar Volume | $627.35K |
Summit Therapeutics News
3 weeks agoinvesting.comWhy is Summit Therapeutics stock surging today?
3 weeks agobarrons.comAMD, Nvidia, Navitas, Summit Therapeutics, Fair Isaac, and More Stocks That Explain Today’s Market
3 weeks agobloomberg.comSummit Therapeutics Jumps on $2 Billion AstraZeneca Investment
1 month agoinvesting.comSummit Therapeutics stock surges on Jefferies upgrade to buy
1 month agoinvesting.comSummit Therapeutics stock rises on positive survival data
2 months agoinvesting.comWhy is Summit Therapeutics stock surging today?
2 months agoinvesting.comSummit Therapeutics stock jumps on partner’s cancer trial data
2 months agoinvesting.comWhy is Summit Therapeutics stock climbing today?
3 months agoinvesting.comSummit Therapeutics stock rises on positive cancer trial data
4 months agoinvesting.comSummit Therapeutics stock rises after CEO share purchase
Summit Therapeutics Top Trades
Summit Therapeutics's top trade so far today returned +0.89%, while the top short trade returned -6.45%.
Summit Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $16.15 |
|---|---|
| 10 Day Moving Average (SMA10) | $16.73 |
| 20 Day Moving Average (SMA20) | $16.65 |
| 50 Day Moving Average (SMA50) | $15.66 |
| 100 Day Moving Average (SMA100) | $15.10 |
| 200 Day Moving Average (SMA200) | $16.31 |
Summit Therapeutics Statistics
| Average Volume (30 Days) | 7.08M |
|---|---|
| P/E Ratio (Current) | -16.44 |
| EPS (Current) | -$1.07 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$459.82M |
| Cash Ratio | 4.05 |
| Current Ratio | 6.96 |
| Quick Ratio | 6.96 |
| Debt to Equity | 0.00 |
| Enterprise Value | $13.61B |
| EV to EBITDA | -15.56 |
| EV to Sales | — |
| Price to Book | 22.27 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -1.14% |
| Return on Equity | -1.36% |
Summit Therapeutics Stock Splits
There have been no stock splits for Summit Therapeutics (SMMT).
Summit Therapeutics Dividends
There have been no dividends for Summit Therapeutics (SMMT).